Parallel Advisors, LLC Dyne Therapeutics, Inc. Transaction History
Parallel Advisors, LLC
- $4.87 Billion
- Q2 2025
A detailed history of Parallel Advisors, LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 62 shares of DYN stock, worth $1,051. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62
Previous 27
129.63%
Holding current value
$1,051
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding DYN
# of Institutions
212Shares Held
122MCall Options Held
36.5KPut Options Held
74.3K-
Ra Capital Management, L.P. Boston, MA9.71MShares$165 Million2.02% of portfolio
-
Janus Henderson Group PLC London, X09.44MShares$160 Million0.05% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$155 Million19.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.65MShares$130 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$125 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $878M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...